| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 722,613 | 625,304 | 662,923 | 1,059,826 | | Cost of Revenue | 439,029 | 383,097 | 420,366 | 673,707 | | | Gross Profit | 283,584 | 242,207 | 242,557 | 386,119 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 234,798 | 222,923 | 236,827 | 269,441 | | Non Recurring |
-
|
-
|
-
| 25,905 | | Others | 29,232 | 29,913 | 29,325 | 29,934 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,554 | (10,629) | (23,595) | 60,839 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 556 | | Earnings Before Interest And Taxes | (49,767) | (10,629) | (23,595) | 61,395 | | Interest Expense | (46,120) | 23,194 | 22,926 | 24,984 | | Income Before Tax | (3,647) | (33,823) | (46,521) | 36,411 | | Income Tax Expense | 506 | 939 | (1,080) | 124,118 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,153) | (34,762) | (45,441) | (87,707) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,153) | (34,762) | (45,441) | (87,707) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,153) | ($34,762) | ($45,441) | ($87,707) |
|
0.01% Nasdaq 0.00%
Income Statement
